| TLR4 links innate immunity and fatty acid–induced insulin resistance H Shi, MV Kokoeva, K Inouye, I Tzameli, H Yin, JS Flier The Journal of clinical investigation 116 (11), 3015-3025, 2006 | 4308 | 2006 |
| Novel role of PKR in inflammasome activation and HMGB1 release B Lu, T Nakamura, K Inouye, J Li, Y Tang, P Lundbäck, SI Valdes-Ferrer, ... Nature 488 (7413), 670-674, 2012 | 823 | 2012 |
| Chronic enrichment of hepatic endoplasmic reticulum–mitochondria contact leads to mitochondrial dysfunction in obesity AP Arruda, BM Pers, G Parlakgül, E Güney, K Inouye, GS Hotamisligil Nature medicine 20 (12), 1427-1435, 2014 | 619 | 2014 |
| Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue KE Inouye, H Shi, JK Howard, CH Daly, GM Lord, BJ Rollins, JS Flier Diabetes 56 (9), 2242-2250, 2007 | 294 | 2007 |
| Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production H Cao, M Sekiya, ME Ertunc, MF Burak, JR Mayers, A White, K Inouye, ... Cell metabolism 17 (5), 768-778, 2013 | 260 | 2013 |
| Diabetes and the hypothalamo-pituitary-adrenal (HPA) axis. O Chan, K Inouye, MC Riddell, M Vranic, SG Matthews Minerva endocrinologica 28 (2), 87-102, 2003 | 240 | 2003 |
| The short-chain fatty acid propionate increases glucagon and FABP4 production, impairing insulin action in mice and humans A Tirosh, ES Calay, G Tuncman, KC Claiborn, KE Inouye, K Eguchi, ... Science translational medicine 11 (489), eaav0120, 2019 | 223 | 2019 |
| A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use S Liu, JD Brown, KJ Stanya, E Homan, M Leidl, K Inouye, P Bhargava, ... Nature 502 (7472), 550-554, 2013 | 214 | 2013 |
| Direct control of hepatic glucose production by interleukin-13 in mice KJ Stanya, D Jacobi, S Liu, P Bhargava, L Dai, MR Gangl, K Inouye, ... The Journal of clinical investigation 123 (1), 2012 | 169 | 2012 |
| Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity A Bartelt, SB Widenmaier, C Schlein, K Johann, RLS Goncalves, K Eguchi, ... Nature medicine 24 (3), 292-303, 2018 | 165 | 2018 |
| Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal … O Chan, K Inouye, M Vranic, SG Matthews Endocrinology 143 (5), 1761-1768, 2002 | 137 | 2002 |
| Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance H Shi, B Cave, K Inouye, C Bjørbæk, JS Flier Diabetes 55 (3), 699-707, 2006 | 135 | 2006 |
| Molecular regulation of the hypothalamo-pituitary-adrenal axis in streptozotocin-induced diabetes: effects of insulin treatment O Chan, S Chan, K Inouye, M Vranic, SG Matthews Endocrinology 142 (11), 4872-4879, 2001 | 135 | 2001 |
| Diabetes impairs hypothalamo-pituitary-adrenal (HPA) responses to hypoglycemia, and insulin treatment normalizes HPA but not epinephrine responses O Chan, S Chan, K Inouye, K Shum, SG Matthews, M Vranic Diabetes 51 (6), 1681-1689, 2002 | 112 | 2002 |
| Insulin alone increases hypothalamo-pituitary-adrenal activity, and diabetes lowers peak stress responses O Chan, K Inouye, E Akirav, E Park, MC Riddell, M Vranic, SG Matthews Endocrinology 146 (3), 1382-1390, 2005 | 96 | 2005 |
| Development of a therapeutic monoclonal antibody that targets secreted fatty acid–binding protein aP2 to treat type 2 diabetes MF Burak, KE Inouye, A White, A Lee, G Tuncman, ES Calay, M Sekiya, ... Science translational medicine 7 (319), 319ra205-319ra205, 2015 | 94 | 2015 |
| The role of adipocyte XBP1 in metabolic regulation during lactation MF Gregor, ES Misch, L Yang, S Hummasti, KE Inouye, AH Lee, B Bierie, ... Cell reports 3 (5), 1430-1439, 2013 | 93 | 2013 |
| Increased oxidative phosphorylation in response to acute and chronic DNA damage LE Brace, SC Vose, K Stanya, RM Gathungu, VR Marur, A Longchamp, ... npj Aging and Mechanisms of Disease 2 (1), 1-11, 2016 | 79 | 2016 |
| Hyperglycemia does not increase basal hypothalamo-pituitary-adrenal activity in diabetes but it does impair the HPA response to insulin-induced hypoglycemia O Chan, K Inouye, EM Akirav, E Park, MC Riddell, SG Matthews, M Vranic American Journal of Physiology-Regulatory, Integrative and Comparative …, 2005 | 66 | 2005 |
| Regulation of liver subcellular architecture controls metabolic homeostasis G Parlakgül, AP Arruda, S Pang, E Cagampan, N Min, E Güney, GY Lee, ... Nature 603 (7902), 736-742, 2022 | 58 | 2022 |
